ATE24999T1 - Antigenisches heilmittel und verfahren zu dessen herstellung fuer die therapie von nichtspezifischen allergischen krankheiten. - Google Patents

Antigenisches heilmittel und verfahren zu dessen herstellung fuer die therapie von nichtspezifischen allergischen krankheiten.

Info

Publication number
ATE24999T1
ATE24999T1 AT82300841T AT82300841T ATE24999T1 AT E24999 T1 ATE24999 T1 AT E24999T1 AT 82300841 T AT82300841 T AT 82300841T AT 82300841 T AT82300841 T AT 82300841T AT E24999 T1 ATE24999 T1 AT E24999T1
Authority
AT
Austria
Prior art keywords
allergic diseases
antigen
therapy
production
nonspecific
Prior art date
Application number
AT82300841T
Other languages
English (en)
Inventor
Tadao Kokubu
Original Assignee
Tadao Kokubu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tadao Kokubu filed Critical Tadao Kokubu
Application granted granted Critical
Publication of ATE24999T1 publication Critical patent/ATE24999T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT82300841T 1981-03-04 1982-02-18 Antigenisches heilmittel und verfahren zu dessen herstellung fuer die therapie von nichtspezifischen allergischen krankheiten. ATE24999T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56029941A JPS57144225A (en) 1981-03-04 1981-03-04 Antigenetic preparation for treating nonspecific allergic diseases and its preparation
EP82300841A EP0059563B1 (de) 1981-03-04 1982-02-18 Antigenisches Heilmittel und Verfahren zu dessen Herstellung für die Therapie von nichtspezifischen allergischen Krankheiten

Publications (1)

Publication Number Publication Date
ATE24999T1 true ATE24999T1 (de) 1987-02-15

Family

ID=12290006

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82300841T ATE24999T1 (de) 1981-03-04 1982-02-18 Antigenisches heilmittel und verfahren zu dessen herstellung fuer die therapie von nichtspezifischen allergischen krankheiten.

Country Status (7)

Country Link
US (1) US4457913A (de)
EP (1) EP0059563B1 (de)
JP (1) JPS57144225A (de)
AT (1) ATE24999T1 (de)
AU (1) AU562279B2 (de)
CA (1) CA1202896A (de)
DE (1) DE3275161D1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8303401D0 (sv) * 1983-06-15 1983-06-15 Pharmacia Ab Beredning och dess anvendning
US4822611A (en) * 1986-12-09 1989-04-18 Immunotec, Inc. Oral hyposensitization in the treatment of allergies
CN113092770A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液白蛋白及其多肽片段在过敏性疾病中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248295A (en) * 1962-12-26 1966-04-26 Canadian Patents Dev Anti-allergic urine extract and method of making same
DE1617806B1 (de) * 1967-02-23 1971-06-09 Momoe Soeda Verfahren zur Herstellung eines Heilmittels gegen allergische Beschwerden
GB1174974A (en) * 1967-02-27 1969-12-17 Momoe Soeda Process for preparation of Medicine for Allergic Disorders
FR6172M (de) * 1967-03-06 1968-07-08
FR2218090A1 (en) * 1973-02-19 1974-09-13 Momoe Soeda Allergic diseases treatment compsn - extracted from urine of patient
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4169139A (en) * 1974-10-07 1979-09-25 Arthur Karler Glyco/proteinaceous materials derivable from beef liver and other tissues useful for the treatment of toxic and allergic conditions
DE2544183A1 (de) * 1975-10-03 1977-04-28 Arthur Karler Verfahren zur herstellung eines biologisch aktiven mucoprotids
JPS5946206B2 (ja) * 1975-10-08 1984-11-10 （株） 目黒研究所 免疫学的活性を有する非病原性好気性コリネバクテリウム培養物の製造法
DE2862107D1 (en) * 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
AU523077B2 (en) * 1978-03-20 1982-07-08 Green Cross Corporation, The Hgi glycoprotein
US4178285A (en) * 1978-12-20 1979-12-11 Felts James M Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
FR2449697A1 (fr) * 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use

Also Published As

Publication number Publication date
DE3275161D1 (en) 1987-02-26
JPS57144225A (en) 1982-09-06
US4457913A (en) 1984-07-03
AU8113082A (en) 1982-09-09
EP0059563A2 (de) 1982-09-08
CA1202896A (en) 1986-04-08
AU562279B2 (en) 1987-06-04
EP0059563B1 (de) 1987-01-21
EP0059563A3 (en) 1984-02-22

Similar Documents

Publication Publication Date Title
ATE228373T1 (de) Unterdrückung von autoimmunkrankheiten durch antigene in wartestellung
ATA84882A (de) Therapeutisches abgabesystem zur verabreichung eines wirkstoffes durch die haut
Kerns et al. Ampicillin rash in children: relationship to penicillin allergy and infectious mononucleosis
DK0461177T3 (da) Humant intra-acrosomalt spermantigen til anvendelse i en svangerskabsforebyggende vaccine
EP0674661A4 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis.
DE69425246D1 (de) Monoklonale antikoerper gegen lfa-1 zur herstellung eines arzneimittels zur vorbeugung der transplantatabstossung von organen
GB1499035A (en) Antistaphylococcus human immune globulin and method of preparing same
DE59608213D1 (de) Arzneimittel zur immuntherapie, enthaltend antikörper, die spezifisch das mhcii-antigen eines zu behandelnden patienten erkennen
ATE24999T1 (de) Antigenisches heilmittel und verfahren zu dessen herstellung fuer die therapie von nichtspezifischen allergischen krankheiten.
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
Udelman et al. Current explorations in psychoimmunology
DE3786173D1 (de) Menschlicher monoklonaler antikoerper und arzneimittel zur prophylaxe und behandlung von infektioesen krankheiten.
SE8402702L (sv) Anvendning av ett specifikt tumorassocierat antigen i hapten, nemligen fukosylsialosylgangliotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
Florin-Christensen et al. Alpha 1 fetoprotein and antialpha 1 fetoprotein in acute viral hepatitis.
GB1422760A (en) Immunoregulation means
Jørgensen et al. Naloxone‐induced reduction of schizophrenic symptoms A CASE REPORT
Marcinkowski The diseases of Alzheimer and Pick from the viewpoint of prevention
Feinberg et al. A method of measuring rate and degree of absorption of antigens: As applied to effects of certain drugs, menstrua, and modes of administration
SU556809A1 (ru) Способ получени антител к австралийскому антигену
Wade Inventor of hybridoma technology failed to file for patent
FR2401164A1 (fr) Nouvelles thieno-oxazines et medicament anti-allergique les contenant
Hinchman et al. Regulation of IgG antibody synthesis by a B cell component.
Keogh et al. Pilot study of low-dose azathioprine in presensitized patients awaiting heart or lung transplantation
Rose et al. Immunological studies in myasthenia gravis
Sullivan Abstract 9. Clinical manifestations of viral illness

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee